Background illustration for clinical trials search

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

Filter

Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant

for
Acute Leukemia, Myelodysplastic Syndrome,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18 - 70+

Code: NCT06265584

Phase 2, Recruiting

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

for
Chronic Lung Disease, Hematopoietic Cell Transplantation,
Location: Ann Arbor MI, Seattle WA, Stanford CA
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 3+

Code: NCT05866302

Recruiting

Umbilical Cord Blood Transplantation From Unrelated Donors

for
Acute Leukemia, Immune Deficiency Disorder,
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 0 - 70+

Code: NCT03016806

Recruiting

Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation

for
Myeloablative Allogeneic Hematopoietic Cell Transplantation,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT05335434

Recruiting

Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation

for
Allogeneic Hematopoietic Cell Transplantation
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT04332341

Early Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

for
Acute Leukemia, Newly Diagnosed, Relapsed
Location: Hartford CT, New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT02677064

Recruiting

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

for
Acute Leukemia of Ambiguous Lineage,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 65

Code: NCT06013423

Phase 2, Recruiting

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

for
Acute Leukemia, Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: Rochester NY, Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06207123

Phase 1, Phase 2, Recruiting

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

for
Acute Leukemia, Acute Leukemia of Ambiguous Lineage,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 2+

Code: NCT06575296

Phase 1, Recruiting

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

for
Acute Leukemia, Acute Lymphoblastic Leukemia,
Location: Pittsburgh PA, Tampa FL, Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 1 - 60

Code: NCT03970096

Phase 2, Recruiting

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

for
Acute Leukemia, Acute Myeloid Leukemia,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 25

Code: NCT03810196

Recruiting

Familial Investigations of Childhood Cancer Predisposition

for
Acute Leukemia, Adenomatous Polyposis, Adrenocortical Carcinoma,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0+

Code: NCT03050268

Recruiting

A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory Acute Leukemias That Are of the Lymphoid Lineage Including Bi-Phenotypic or Undifferentiated Leukemias

for
Refractory Acute Leukemia, Relapsed Acute Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 2 - 21

Code: NCT06466395

Phase 1, Recruiting

Improving White Blood Cell Collection From Healthy Donors

for
Allogeneic Granulocyte Donation
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)

Sex: All

Age: 18 - 70+

Code: NCT01553214

Recruiting

Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia

for
Acute Leukemia
Location: Saint John, Ottawa, Kingston, Toronto, Hamilton
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT04224974

Recruiting

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

for
Acute Leukemia, Acute Myeloid Leukemia,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 0 - 60

Code: NCT03314974

Phase 2, Recruiting

Improve Outcomes for Older Allogeneic Transplant Recipients

for
Allogeneic Transplantation
Location: Philadelphia PA
Sponsor: Abramson Cancer Center at Penn Medicine

Sex: All

Age: 60+

Code: NCT05612789

Recruiting

Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia

for
Relapsed/Refractory KMT2A-r Acute Leukemia,
Location: Boston MA, New York NY, Philadelphia PA, Toronto,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 21

Code: NCT06376162

Phase 1, Recruiting

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

for
Clonal Mast Cell Disease, KIT D816V Mutation,
Location: Warwick RI, New York NY, Glenn Dale MD, Chapel Hill NC,
Sponsor: Blueprint Medicines Corporation

Sex: All

Age: 18+

Code: NCT07143669

Recruiting

A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias

for
Refractory Acute Leukemia, Pediatric Relapsed
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 2 - 21

Code: NCT06397027

Phase 1, Recruiting

What stem cell therapy clinical trials are studying now

Transplants for blood cancers and blood disorders. Hematopoietic stem cell transplant replaces a person's blood forming system with their own stored cells or a donor's. Trials test safer conditioning, better donor matching, including half matched family donors for sickle cell disease, and ways to prevent graft versus host disease.

Transplants for autoimmune disease. Resetting the immune system with a person's own stem cells is being tested against the best available drugs in relapsing multiple sclerosis, in a Phase 3 trial funded by the National Institutes of Health at more than 20 US sites.

Mesenchymal stromal cells. Cells from bone marrow or fat that calm inflammation, tested for Crohn's disease, graft versus host disease, and hard to heal wounds. The first one was approved in 2024 after decades of trials.

Cells made from stem cells. Lab grown dopamine neurons for Parkinson's disease and insulin producing islet cells for type 1 diabetes, both now in or entering late stage trials.

Gene corrected stem cells. A person's own blood stem cells are edited to fix a mutation and returned. Two such therapies for sickle cell disease were approved in 2023; see gene therapy clinical trials. Immune cell therapies such as CAR T are a different technology, covered on our CAR T cell therapy page.

Stem cell transplants are part of care for leukemia, lymphoma, and multiple myeloma; each page lists its own studies.

Article preview image

New to research? Read how informed consent works.

Informed Consent in Clinical Trials: What Is It and How It’s Obtained

Who can participate in stem cell therapy clinical trials?

Is stem cell therapy safe?

How long does stem cell therapy last?

Do stem cell trial participants get paid?

How to enroll in a stem cell clinical trial